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Strengths and limitations of this study
 ► Consecutive follow- up data of cognitive perfor-
mance, behaviour and quality of life are available 
throughout childhood (age 1–10 years) from this 
cohort of children with congenital heart disease.
 ► Executive function (EF) abilities will be assessed 
comprehensively using a battery of standardised 
neuropsychological tests in order to measure the 
core domains of EF: inhibition, cognitive flexibility, 
fluency, working memory, planning and risk taking.
 ► The potential risk for a recruitment bias of healthy 
controls with an above- average socioeconomic sta-
tus exists as they are more likely to consent to serve 
as controls.
 ► Heterogeneity of types of heart defects may result 
in a potential variety of cognitive outcomes in the 
patient group.
AbStrACt
Introduction Congenital heart disease (CHD) is the 
most frequent congenital malformation. With recent 
advances in medical care, the majority of patients with 
CHD survive into adulthood. As a result, interest has 
shifted towards the neurodevelopmental outcome of these 
patients, and particularly towards the early detection and 
treatment of developmental problems. A variety of mild 
to moderate cognitive impairments as well as emotional 
and behavioural problems has been observed in this 
population. However, a more detailed assessment of the 
various domains of executive function and their association 
with structural and functional brain development is lacking. 
Therefore, the current study will examine all domains of 
executive function and brain development in detail in a 
large sample of children and adolescents with CHD and 
healthy control children.
Methods and analysis A total of 192 children and 
adolescents with CHD aged 10–15 years, who participated 
in prospective cohort studies at the University Children’s 
Hospital Zurich, will be eligible for this study. As a control 
group, approximately 100 healthy children will be enrolled. 
Primary outcome measures will include executive function 
abilities, while secondary outcomes will consist of other 
neurodevelopmental measures, including intelligence, 
processing speed, attention, fine motor abilities and 
brain development. An MRI will be performed to assess 
structural and functional brain development. Linear 
regression analyses will be applied to investigate group 
differences and associations between executive function 
performance and neurodevelopmental measures.
Ethics and dissemination This study is supported by the 
Swiss National Science Foundation (SNF 32003B_172914) 
and approved by the ethical committee of the Canton 
Zurich (KEK 2019–00035). Written informed consent will 
be obtained from all the parents and from children aged 14 
years or older. Findings from this study will be published 
in peer- reviewed journals and presented at national and 
international conferences for widespread dissemination of 
the results.
IntroduCtIon
Congenital heart disease (CHD) occurs in 
about 8/1000 live births1 and constitutes the 
most frequent congenital malformation. With 
dramatic improvements in surgical manage-
ment and in neonatal and perioperative care, 
survival rates have significantly increased.2 3 
As cardiac outcome is often good, enabling 
these children to survive into adulthood, 
interest has mounted in the neurodevelop-
mental and behavioural outcomes of these 
children. Neurodevelopmental impairments 
in this at risk population can occur across 
all developmental domains, particularly in 
cognitive, language, visuoperceptual and 
motor abilities.4 Further, children with CHD 
are at an increased risk for behavioural and 
emotional problems.5 6 These problems are 
likely associated with lifelong individual 
psychological and societal financial burdens.7
Executive functions (EF) comprise a set 
of interrelated higher- order cognitive abili-
ties that facilitate purposeful, goal- oriented 
behaviour. EF include domains such as inhibi-
tion, working memory and cognitive flexibility, 
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verbal fluency and planning.8 EF have a protracted devel-
opmental trajectory: they emerge in early childhood and 
evolve during early adolescence into young adulthood,9 
paralleling the maturation of prefrontal structures10 and 
have been closely linked to academic achievement in 
healthy children.11 Deficits may become apparent only 
during early adolescence, a time when personal autonomy 
develops and increasing demands are placed on various 
EF within both the home and school environments. While 
EF difficulties have been well- described in another at risk 
population of preterm born children,12 information on 
the development of EF in CHD children is limited. Most 
studies have only reported individual aspects of EF (eg, 
working memory, planning)13 14 or have assessed exec-
utive dysfunction in daily living by means of a question-
naire,15 but only a few previous studies have applied more 
comprehensive cognitive test batteries to assess a wider 
spectrum of EF. Two studies in children 5–7 years old 
with transposition of the great arteries (TGA) reported 
EF difficulties in cognitive inhibition, working memory, 
cognitive flexibility and planning, even though IQ was in 
the normal range.16 17 Another study in 10–19- year- old 
CHD children and adolescents reported EF impairments 
in flexibility and problem solving. Another study in 
adolescents reported worse performance on tests of EF in 
different types of heart defects, such as tetralogy of Fallot, 
TGA and hypoplastic left heart syndrome.18–20 Another 
important aspect of cognitive function is processing 
speed. Processing speed seems to be a strong determinant 
of later EF and academic achievement in children with 
TGA21 and has also been shown to mediate improvements 
in EF in very preterm born children at school- age.22
MRI studies in fetuses, neonates, children and adoles-
cents with CHD have shown that brain alterations and 
delayed brain maturation already occur prenatally and 
that there are persistent global and local reductions in 
brain volume, particularly in the white matter, the hippo-
campus and the cortical grey matter.23–25 However, the 
implications of structural changes, delayed brain matu-
ration, reduced brain volumes and poorer connectivity, 
for later neurodevelopmental outcome are still unclear. 
Delayed brain maturation in the CHD population may 
lead to overall slower development until school age with 
consecutively delayed development of higher order brain 
networks and associated functions such as EF. Previous 
studies on healthy individuals and patients with a variety 
of neurological or psychiatric conditions have shown that 
EF performance is dependent on frontoparietal as well as 
the cingulo- opercular networks and the cerebellum.26 27
A systematic review of imaging findings in adolescents 
and young adults with CHD estimated the odds of brain 
abnormalities to be 15.6 times higher compared with 
healthy controls, with focal and multifocal lesions being 
the most frequent abnormalities.24 There is emerging 
evidence that brain alterations revealed by volumetric, 
structural and functional analyses are associated with 
poorer neurocognitive performance.24 Brain volumes 
in adolescents with a wide variety of CHD diagnoses are 
globally reduced and correlate with functional deficits.28 
With regard to brain structural connectivity, so far, only 
very few studies reported on the relation of diffusion 
tensor imaging (DTI) and neurodevelopmental outcome 
in adolescents with CHD. A study in patients with TGA 
revealed that lower fractional anisotropy in the left pari-
etal region, right precentral region and right frontal 
region was associated with impaired EF performance and 
lower academic achievement.29 Two studies showed that 
reduced fractional anisotropy in the white matter tracts 
was associated with impairments in various cognitive 
domains such as IQ, processing speed and memory.30 31 
Further, a connectomic analysis revealed a link between 
decreased global efficiency, increased modularity, 
increased small- worldness and worse EF and academic 
achievement.32 However, to date there is only limited 
information regarding EF impairments in adolescents 
with CHD, risk factors for impaired EF and the associa-
tion between impaired EF and brain abnormalities.
Aims and hypothesis of study
The main aim of this project is to assess the extent and 
spectrum of EF deficits in relation to cerebral MRI 
findings, brain volumes and connectivity in children 
and adolescents aged 10–15 years who have undergone 
cardiopulmonary bypass (CPB) surgery for severe CHD.
1. To evaluate a broad spectrum of EF in children with se-
vere CHD between the age 10–15 years in comparison 
to healthy controls. Hypothesis: Children/adolescents 
with CHD will show impairments in overall EF and 
across all subdomains of EF with the strongest effects 
in flexibility according to Cassidy et al.21
2. To assess structural, morphometric and connectivity 
changes using cerebral MRI and to correlate these with 
EF performance in children with CHD between the 
ages 10 and 15 years. Hypothesis: Children/adolescents 
with CHD will show brain atrophy and small white mat-
ter lesions, reduced global and regional brain volumes. 
Connectivity analyses will demonstrate network alter-
ations in the frontoparietal and/or cingulo- opercular 
networks, which will correlate with EF performance.
3. To evaluate and identify patient- specific and treatment- 
associated risk factors for poorer EF and, in a subsa-
mple of children, to evaluate neonatal cerebral MRI 
biomarkers for poorer EF. Hypothesis: We will be 
able to identify specific risk factors (patient- specific, 
treatment- associated and cerebral imaging) which will 
constitute early biomarkers for later EF difficulties.
MEthodS And AnAlySIS
Study participants
We will recruit the participants at the age of 10–15 years 
from two prospective cohort studies, the REACHOUT 
(REsearch and Assessment of Child Health and OUTcome) study 
and the Heart and Brain cohort 1 study. Variables describing 
medical, neurological, perioperative and demographic 
properties have been collected prospectively.
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Table 1 Study specific test battery to assess executive 
function ability
Assessed domains Applied assessment tool
Inhibition Go/NoGo (TAP)
Colour Word Interference Task (D- KEFS)
Working Memory Digit Span forward & backward (WISC- 
IV)
Letter- number Sequencing (WISC- IV)
Corsi Block Tapping Test
Cognitive Flexibility Trail Making Task (D- KEFS)
Flexibility (TAP)
Planning Tower Task (D- KEFS)
Fluency Verbal Fluency (RWT)
Design Fluency (D- KEFS)
Risk taking Balloon Analogue Risk Task For Youth 
(BART- Y)
In the Reachout study, children were enrolled between 
July 2004 and July 2009 prior to CPB surgery and under-
went comprehensive and standardised neurodevelop-
mental and behavioural assessments at defined ages (1, 4, 
6 and 10 years). Quality of life and factors associated with 
quality of life were assessed through questionnaires at all 
time points. For the 1, 4 and 6 year examination, children 
with a genetic comorbidity were also examined.
In the Heart and Brain cohort 1, children with CHD 
without a genetic comorbidity who were born between 
November 2009 and February 2012 and who had CPB 
surgery during the neonatal period or early infancy 
underwent neonatal preoperative and postoperative 
cerebral MRI assessment. They had neurodevelopmental 
assessments at the age of 1, 4 and 6 years of age.
Children will be eligible for the current study if they 
were born between 2004 and 2012 and underwent their 
first CPB surgery before the age of 6 years, are currently 
living in Switzerland and have not been diagnosed with 
a genetic comorbidity or dysmorphic syndrome. There 
are 192 children (125 male) eligible (REACHOUT study 
n=160, Heart and Brain cohort 1 n=32). The majority are 
diagnosed with a TGA (n=68). Other diagnoses include 
univentricular CHD (n=36) and other severe CHD 
requiring CPB surgery in the neonatal period or during 
early infancy. If necessary, to ensure the required power 
by means of a sufficient sample size, additional patients 
with CHD meeting our inclusion criteria can be recruited 
from the paediatric cardiology clinic of the University 
Children’s Hospital Zurich and from collaborating paedi-
atric cardiology centres.
Recruitment of all of the patients with CHD will be 
done with an invitation letter sent by post to their parents, 
followed by contact via telephone. Healthy, term- born 
children will be recruited as a control group. Children 
from the control group will be recruited from peers of 
the participating patients with CHD and through adver-
tisements in schools. Controls will be excluded if they 
are diagnosed with a significant developmental disorder 
(specific learning disorder or attention deficit hyperac-
tivity disorder) or any neurological diagnoses.
This research will be done without direct patient 
involvement in regard to commenting on the study 
design, developing patient relevant outcomes or inter-
preting the results. Patients were not invited to contribute 
to the writing or editing of this document for readability 
or accuracy.
outcome measures
Primary outcome measures will include EF abilities, while 
secondary outcomes will consist of other neurodevel-
opmental measures, including intelligence, processing 
speed, attention, fine motor abilities and brain devel-
opment. An MRI will be performed to assess structural 
and functional brain development. Questionnaires, 
filled out by the parents and the children, will be used to 
gather information on behavioural problems, quality of 
life, personality and the quality of the family and social 
environment.
Primary outcome measures: executive functions
An extensive neuropsychological test battery consisting 
of well established, standardised tests will be used to 
assess EF performance with regard to inhibition, working 
memory, cognitive flexibility, planning, fluency and risk- 
taking behaviour (table 1).
The Delis- Kaplan Executive Function System33 encom-
passes a set of key tasks to assess EF in a standardised 
manner. In this study, we will use the Trail Making Test 
(flexibility), the Color- Word Inference Task (inhibition), the 
Tower Task (visual- spatial planning) and the Design Fluency 
Test (visual- spatial fluency). The Test of Attentional Perfor-
mance (TAP)34 is a validated set of computer- based tests 
to selectively assess specific aspects of attention processes. 
In our study, the subtests Flexibility and Go/NoGo (inhibi-
tion) will be conducted. The Regensburger Verbal Fluency 
Test35 has been validated in German speaking populations 
and assesses phonetic and semantic verbal fluency. Verbal 
working memory will be assessed with the two subtests 
Digit span and Letter- number sequencing from the WISC- IV. 
Visual- spatial working memory will be assessed using the 
Corsi Block Tapping- Test36 with a forward and backward 
condition.
Risk taking behaviour, a form of emotion- charged 
EF,37 will be measured by the youth- version of the Balloon 
analogue risk task.38 For this study, the task will be imple-
mented in PsychoPy.39 All settings will be adopted from 
the original study by Lejuez.38
A global composite score for EF as well as composite 
scores for each subtype of EF will be calculated using 
z- transformed scores of the tests measuring inhibition, 
working memory, cognitive flexibility, planning and 
fluency.
To assess EF skills in daily life, parents will complete the 
validated questionnaire Behaviour Rating Inventory of Exec-
utive Functions40.
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Table 2 List of applied questionnaires
Assessed domains 
and subdomains Questionnaire
Completed 
by
Information on child
Quality of life Kidscreen-2749
Kidscreen-10
Parent
Child
Resilience 
(Personality trait)
Resilience Scale 1350 Child
Executive functions 
in daily living
Behaviour Rating Inventory 
for Executive Function
Parent
Behavioural 
difficulties
Strength and Difficulties 
Questionnaire51
Parent
Family situation
Family environment Family Relationship Index52 Parent
Parenting style and 
bonding
Parenting Style inventory53
Zurich Brief Questionnaire 
for the Assessment of 
Parental Behavior54
Parent
Child
Parental mental 
health
Brief Symptom Inventory 
1855
Parent
Parental resilience
(Personality trait)
Resilience Scale 13 Parent
Parental quality 
of life
Aversive life events
36- Item Short Form 
Survey56
Life Event Scale*
Parent
Parent
Social situation
Social support Social Support 
Questionnaire57
Parent
Socioeconomic 
status
Information on maternal 
education and parental 
occupation
Parent
*Landolt MA, Vollrath M. Life event scale. University Children's 
Hospital Zurich, Zurich, Switzerland, 1998.
Secondary outcome measures
Neurodevelopmental measures: intelligence, processing speed, 
attention and fine motor abilities
The IQ will be estimated by means of a well- established 
four- subtest short version of the WISC- IV that correlates 
highly (r>0.90) with the full version.41 42 A combination of 
the subtests Matrices, Similarities, Letter Number Sequencing 
and Symbol Search will be assessed. Processing speed will 
be assessed with the subtest Coding and Symbol Search from 
the WISC- IV and a global score for processing speed will 
be estimated according to the manual of the WISC- IV. 
Attention will be measured using the subtest Alertness of 
the Test of Attentional Performance (TAP). To measure 
fine motor abilities, the subtest Pegboard of the Zurich 
Neuromotor Assessment, Second edition43 will be used.
The measures for processing speed, attention and fine 
motor abilities will be used to ensure that differences in 
EF performance are not caused by differences in these 
domains.
The neurodevelopmental test battery, including the 
tests for EF performance, intelligence, processing speed, 
attention and fine motor abilities will take approximately 
2 ½ hours. The tests will be conducted in a randomised 
order to avoid effects of fatigue and motivation loss. 
Trained psychologists and paediatricians from the Child 
Development Center at the University Children’s Hospital 
Zurich will administer and interpret the tests. The radiol-
ogist reviewing the MR scans will be blinded.
Magnetic resonance imaging
Cerebral MRI will be performed on a 3T GE MR750 
scanner. Suitability for MRI acquisition will be assessed 
prior to the study participation using a safety- screening 
questionnaire, which will be filled out by the parents. All 
surgery reports will be screened for magnetic implants to 
confirm MR safety. For the MRI scan, hearing protection 
will be provided with earplugs and headsets. The heart 
rate and respiratory rate as well as the specific absorption 
rate will be monitored.
High- resolution three- dimensional T1 weighted images 
will be acquired using a three dimensional spoiled 
gradient echo pulse sequence (SPGR) to assess brain 
volumes, cortical thickness and the presence of white 
matter lesions or other abnormalities. SPGR images will 
be acquired using the following parameters: repetition 
time/echo time (TR/TE)=11/5 ms; inversion time=600 
ms; flip angle=8°; reconstructed matrix=256 × 256; field 
of view (FOV)=26 cm; 176 contiguous axial slices, 1 mm 
slice thickness.
For the investigation of global network connectivity 
and maturation of white matter microstructure, DTI 
will be performed. The imaging slices will be oriented 
parallel to the anterior commissure—posterior commis-
sure plane, with parameters: TR/TE=7500/89 ms; acqui-
sition matrix=96×96; FOV=28 cm; slice thickness 3.6 mm. 
A total of 35 diffusion- weighted gradient directions will 
be acquired with four interleaved non- diffusion weighted 
images with b=0 s/mm2.
Functional resting state MRI will be conducted to 
analyse functional connectivity and to map connec-
tome networks in combination with structural DTI data. 
Patients will be asked to close their eyes during this 
sequence. The following parameters will be applied: TR/
TRE=1925/17 ms; flip angle=74°, FOV=24 cm; acquisition 
matrix=64×64; slice thickness 3.6 mm.
In a subset of 32 participants, preoperative and postop-
erative neonatal brain imaging (MRI) will be investigated 
in relation to adolescent MRI.44
Questionnaires
In order to evaluate behaviour, quality of life, resilience 
and the family and social situation, participants and their 
parents will be asked to complete a set of questionnaires.
Participants will fill out three questionnaires on quality 
of life, resilience and the parenting style of their parents.
Parents of the participating children/adolescents will 
be asked to complete questionnaires about their child’s 
behaviour and quality of life, as well as on their own well- 
being (physical and mental health) and various aspect of 
their family and social situation (see table 2 for detailed 
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information on the applied questionnaires). Socioeco-
nomic status (SES) will be estimated by means of two 
six- point scales of maternal education and paternal occu-
pation with a range from 2 to 12.45
Patient and public involvement
Patients were neither involved in developing the research 
questions nor the study design. However, patients were 
involved in the recruitment of healthy controls, as they were 
encouraged to bring a friend to best possible balance demo-
graphic variables (eg, age, sex and SES) between groups.
The results from this study will be disseminated to 
participants and their families by means of newsletters, 
patient organisation platforms and public informative 
meetings.
Statistical analyses
Study design and power calculation
Based on a previous study on EF performance in adoles-
cents with CHD,21 we expect a minimum effect size of 
0.55 for differences in the different domains of EF, with 
a range in effect size from 0.55 (planning) to 0.81 (flex-
ibility) when comparing patients with CHD and healthy 
controls. Considering the smallest effect size of 0.55, a 
minimum sample size of 70 participants per group is 
needed, assuming an alpha level of 0.05 and a power of 0.9. 
Considering that we plan to investigate global EF and its 
six domains (see table 1), a Bonferroni correction for these 
additional variables would result in an alpha level of 0.007 
(alpha corrected=0.05/7=0.007). Under this assumption, 
the minimum sample size per group would then be 104. 
Based on the high follow- up rates from the previous neuro-
developmental assessments of the REACHOUT cohort,46 
this sample size is assumed to be achievable.
As often seen when recruiting healthy controls, there 
might be a sampling bias for higher functioning individ-
uals47 which may be evident with regard to IQ and SES. 
These imbalances will be taken into account in the statis-
tical analysis.
Statistics
Descriptive statistics will include mean and SD for contin-
uous variables and number and percentage for categorical 
variables. T- tests will be conducted for continuous variables 
and χ2 tests for categorical variables.
Linear regression models will be used in order to inves-
tigate differences between the patients with CHD and 
healthy controls in EF abilities. The independent variable 
will be group status (patients with CHD, healthy controls) 
and other potential cofounders, such as socioeconomic 
status, age and sex will be considered. Posthoc analyses 
will be conducted to investigate whether the type of CHD 
has an effect on outcome. We will aim for balanced groups 
when categories are selected for posthoc analyses.
Further associations between secondary variables, such as 
MR parameters for brain development, will be investigated 
using linear regression analyses. For these models, group 
and potential cofounders will be included in the models. 
Regarding brain network analysis, structural DTI and func-
tional resting- state MRI data will be combined using graph 
theory measures, such as topological organisation (modu-
larity, small- world and rich- club indices), integration and 
segregation.
All analyses will be conducted with an alpha level of 0.05. 
Bonferroni or false discovery rate correction will be applied 
if needed. The statistical programming language R48 will be 
used for all analyses. In the case that the data do not meet 
the linearity and normality assumptions, non- parametric 
tests will be used to ensure the interpretability of the results.
Ethics and dissemination
The protocol was approved by the ethical committee of the 
Canton of Zurich in Switzerland (BASEC- Nr: 2019–00035). 
Written informed consent will be obtained from the 
parents and children aged 14 years or older. Data handling, 
record keeping and archiving will be done according to the 
guidelines given by the ethical committee. For widespread 
dissemination, the results of this study will be presented at 
national and international conferences, published in peer- 
reviewed journals and presented to parent organisations 
and healthcare stakeholders.
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